共 6 条
[1]
[Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
[3]
Centers for Disease Control and Prevention, ANT RES THREAT SEARC